Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

By J. Heit, D. Mohr, M. Silverstein, T. Petterson, W. O'Fallon, L. Melton. Archives of Internal Medicine, 2000

946 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Epidemiology of cancer-associated venous thrombosis. (2013, background): “[66-68] Cancer patients are at an approximately two to three-fold increased risk of recurrent venous thrombosis compared with non-cancer patients.[46,67-69] Prandoni and coworkers followed 355 consecutive patients with a first episode of DVT for eight years and found a two-fold risk of recurrent ven”
Venous thromboembolism (VTE) in Europe (2007, methodology): “Table 5: Probability of recurrence of venous thromboembolism (10, 34) and associated outcomes (10, 18) in the at-risk population.”
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. (2012, background): “Treatment Factors: The risk of recurrent VTE decreases rapidly after starting anticoagulant therapy, with a much higher risk during the first week (or month) compared with the second week (or month).(169,170) A recurrence soon after starting therapy can generally be managed by a time-limited (eg, 1 ”
Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prévention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study (2005, background): “Cardiac or respiratory insufficiency, n (%) 47 (24) 39 (20)”
Epidemiology and risk factors for venous thrombosis. (2007, background): “In one study, older age and obesity were associated with higher recurrence risks (56).”